Recombinant Salmonella typhimurium Secretion system apparatus protein ssaK (ssaK)

Shipped with Ice Packs
In Stock

Description

Functional Role in Virulence

SsaK is indispensable for T3SS-2 effector secretion and bacterial pathogenesis:

  • Secretion apparatus assembly: SsaK facilitates the structural integrity of the T3SS-2 needle complex. Deletion of ssaK abolishes secretion of translocon proteins (e.g., SseB, SseC, SseD) and effectors like SseJ and SopD2 .

  • Intracellular survival: ssaK mutants fail to replicate within macrophages and show attenuated virulence in murine infection models .

  • Chaperone interactions: SsaK indirectly supports effector/chaperone complexes (e.g., SsaE-SseB) by enabling ATP-dependent dissociation via SsaN .

Mutant Phenotypes

  • Δ ssaK strains:

    • Fail to secrete SPI-2 effectors in vitro and translocate proteins into host cells .

    • Lose systemic infectivity in mice, with reduced bacterial loads in spleen and liver .

  • Complementation: Functional T3SS-2 is restored when ssaK is reintroduced .

Interaction Networks

  • SsaK-SsaN-SsaQ complex: Co-localizes to the bacterial membrane and is essential for effector secretion .

  • Regulatory crosstalk: SsaK expression is upregulated in Δ hha Δ ydgT mutants, linking it to horizontal gene regulation .

Applications in Biotechnology

Recombinant SsaK is leveraged in multiple research contexts:

  • Pathogenesis studies: Used to dissect T3SS-2 assembly and effector translocation mechanisms .

  • Vaccine development: Attenuated Salmonella strains with ssaK deletions serve as candidates for live-vector vaccines .

  • Protein delivery systems: Engineered Salmonella with intact SsaK can deliver heterologous proteins (e.g., DARPins, monobodies) into eukaryotic cells via T3SS-1/2 hybrids .

Product Specs

Form
Lyophilized powder. We will ship the in-stock format preferentially. If you have special format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult local distributors for specific delivery times. All proteins are shipped with blue ice packs by default. Request dry ice in advance for an extra fee.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
ssaK; STM1411Secretion system apparatus protein SsaK
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-224
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720)
Target Names
ssaK
Target Protein Sequence
MSFTSLPLTE INHKLPARNI IESQWITLQL TLFAQEQQAK RVSHAIVSSA YRKAEKIIRD AYRYQREQKV EQQQELACLR KNTLEKMEVE WLEQHVKHLQ DDENQFRSLV DHAAHHIKNS IEQVLLAWFD QQSVDSVMCH RLARQATAMA EEGALYLRIH PEKEALMRET FGKRFTLIIE PGFSPDQAEL SSTRYAVEFS LSRHFNALLK WLRNGEDKRG SDEY
Uniprot No.

Target Background

Function
Part of the type III secretion system (T3SS or injectisome), which injects bacterial effector proteins into eukaryotic host cells. Regulates SsaN/SctN2 ATPase activity.
Database Links

KEGG: stm:STM1411

STRING: 99287.STM1411

Subcellular Location
Cytoplasm.

Q&A

What is SsaK and what role does it play in Salmonella typhimurium?

SsaK is a critical component of the Type III Secretion System (T3SS-2) in Salmonella typhimurium. It forms part of the C-ring complex along with proteins SsaN (an ATPase) and SsaQ. This complex is essential for the function of T3SS-2, which enables Salmonella to deliver effector proteins directly into host cells. SsaK is considered indispensable for T3SS function, and mutations in the ssaK gene result in significantly attenuated virulence . The protein plays a crucial role in the assembly of the secretion apparatus that allows Salmonella to survive and replicate within host cells during infection.

How does SsaK contribute to bacterial pathogenesis?

SsaK contributes to pathogenesis by enabling the proper assembly and function of the T3SS-2 machinery. As part of the C-ring complex, it helps coordinate the secretion of virulence effectors from the bacterial cytoplasm directly into host cells . These effectors modify host cell functions to create a protective niche for intracellular bacterial replication. The T3SS-2 system, including SsaK, is particularly important for Salmonella's survival within macrophages and for establishing systemic infection. Without functional SsaK, the T3SS-2 apparatus cannot properly assemble, resulting in a bacterium unable to deliver the effectors necessary for intracellular survival and replication .

What experimental systems are available to study SsaK function?

Several experimental systems can be employed to study SsaK:

  • Genetic manipulation: Creating ssaK mutants, complementation strains, and tagged versions for functional studies.

  • Protein expression systems: Recombinant expression of SsaK alone or with its binding partners (SsaN and SsaQ) in E. coli or other expression hosts .

  • In vitro reconstitution: Purification of SsaK and associated proteins to study complex formation and biochemical activities.

  • Cell culture models: Infection of macrophages or epithelial cells with wild-type or ssaK mutant Salmonella to assess effects on intracellular survival.

  • Animal infection models: Typically mice, to study the impact of ssaK mutations on virulence and pathogenesis.

  • Structural biology approaches: X-ray crystallography or cryo-electron microscopy to determine SsaK structure alone or in complex with partners.

What are optimal conditions for inducing T3SS-2 expression when studying SsaK?

For studying SsaK in laboratory settings, proper induction of T3SS-2 expression is crucial. The optimal conditions that mimic the environment of the Salmonella-containing vacuole include:

ParameterOptimal ConditionNotes
pH5.8Mimics acidified phagosome environment
Mg²⁺ concentration8-10 μMLow magnesium triggers expression
Carbon sourceMinimal mediaLimited nutrients enhance expression
Growth phaseLate exponential to early stationaryAllows for accumulation of regulatory factors
Temperature37°CSimulates host body temperature
Growth duration16-24 hoursAllows for complete assembly

Under these conditions, the SsaN-SsaK-SsaQ complex properly forms and co-localizes to the membrane fraction, allowing for functional studies of the T3SS-2 apparatus . Researchers should verify induction by monitoring expression of SPI-2 genes using reporter systems or Western blotting.

How can protein-protein interactions involving SsaK be effectively studied?

Based on methods used to study SsaN interactions in the research literature , several approaches are recommended for investigating SsaK interactions:

  • Co-immunoprecipitation (Co-IP): Using antibodies against SsaK to pull down protein complexes from Salmonella lysates prepared under T3SS-2 inducing conditions. This method can confirm the interaction between SsaK, SsaN, and SsaQ as observed in previous studies .

  • Bacterial two-hybrid assays: To identify direct binary interactions and map interaction domains between SsaK and other T3SS components.

  • Pull-down assays: Using recombinantly expressed and purified tagged versions of SsaK to identify binding partners from bacterial lysates.

  • Surface Plasmon Resonance (SPR) or Isothermal Titration Calorimetry (ITC): For quantitative measurement of binding affinities between SsaK and its binding partners.

  • Cross-linking followed by mass spectrometry: This approach can identify proximity relationships within the SsaK-containing complex under near-native conditions.

  • Fluorescence microscopy with tagged proteins: To visualize co-localization of SsaK with its binding partners in bacterial cells under inducing conditions.

What methodology should be used to purify functional recombinant SsaK protein?

While specific protocols for SsaK purification are not detailed in the search results, the following methodological approach is recommended based on known properties of T3SS components:

  • Cloning strategy:

    • Clone the ssaK gene into an expression vector with an affinity tag (His6, GST, or MBP)

    • Consider co-expression with binding partners SsaN and SsaQ to improve solubility

  • Expression conditions:

    • Test multiple E. coli strains (BL21(DE3), Rosetta, Arctic Express)

    • Optimize induction temperature (16-30°C) and IPTG concentration (0.1-1.0 mM)

    • Consider auto-induction media for gentle expression

  • Lysis and extraction:

    • Use mild detergents if membrane association is suspected

    • Include protease inhibitors and reducing agents

    • Test various buffer conditions (pH 6.0-8.0, 150-500 mM NaCl)

  • Purification steps:

    • Initial affinity chromatography based on chosen tag

    • Ion exchange chromatography as an intermediate step

    • Size exclusion chromatography for final polishing and complex analysis

    • Verify purity by SDS-PAGE and identity by Western blot or mass spectrometry

  • Functional validation:

    • Assess complex formation with SsaN and SsaQ by analytical size exclusion

    • Test binding to known interacting partners

    • Evaluate stability under various storage conditions

What is known about the structural and functional relationship between SsaK and the ATPase SsaN?

The interaction between SsaK and the ATPase SsaN is critical for T3SS-2 function. Research has shown that:

  • SsaN directly interacts with SsaK and SsaQ to form the C-ring complex .

  • This complex co-localizes to the membrane fraction under T3SS-2 inducing conditions, suggesting proper positioning of the machinery .

  • SsaN has been demonstrated to hydrolyze ATP in vitro, providing energy for protein unfolding and translocation .

  • Both proteins are essential for T3SS function and Salmonella virulence in vivo .

The functional relationship likely involves:

  • SsaK providing structural support and proper positioning for the ATPase

  • SsaK potentially regulating SsaN ATPase activity through protein-protein interactions

  • The complex serving as a platform for substrate recognition and initial processing

Detailed molecular mechanisms of how SsaK influences SsaN activity remain to be fully elucidated and represent an important area for future research.

How can contradictory findings about SsaK function be reconciled in research?

When researchers encounter contradictory findings regarding SsaK function, several systematic approaches can help reconcile the discrepancies:

  • Standardize experimental conditions: The function of T3SS-2 components heavily depends on specific inducing conditions . Researchers should:

    • Use identical growth conditions and media compositions

    • Standardize pH and magnesium concentrations

    • Harvest bacteria at consistent growth phases

  • Consider strain variations: Different Salmonella strains might show variations in SsaK sequence or regulation. Comparative genomics and complementation studies can address this factor.

  • Examine interaction contexts: Since SsaK functions within a complex with SsaN and SsaQ , its behavior might differ depending on which interacting partners are present.

  • Apply multiple methodologies: Using various complementary techniques (genetic, biochemical, structural) provides a more complete understanding than relying on a single approach.

  • Utilize contradiction retrieval approaches: Advanced computational methods, similar to those described for sentence embedding , could potentially be adapted to systematically identify and analyze contradictions in the scientific literature about SsaK.

How can SsaK be exploited for the development of recombinant attenuated Salmonella vaccines (RASVs)?

The essentiality of SsaK for T3SS-2 function and Salmonella virulence makes it a promising target for RASV development . Several strategic approaches include:

  • Regulated expression systems: Similar to the arabinose-regulated systems described for other virulence genes , placing ssaK under the control of an inducible promoter could create strains that:

    • Are sufficiently virulent to colonize lymphoid tissues

    • Become attenuated in vivo after arabinose depletion

    • Maintain immunogenicity while ensuring safety

  • Targeted mutations: Engineering specific mutations in ssaK that:

    • Partially disrupt T3SS-2 function without completely abolishing it

    • Allow limited effector delivery sufficient for immune stimulation

    • Reduce pathogenicity while maintaining immunogenicity

  • SsaK as part of a delivery platform: Since the T3SS-2 naturally delivers proteins into host cells, engineered systems with modified SsaK could:

    • Deliver heterologous antigens directly to the host cell cytosol

    • Target specific antigen-presenting cells

    • Enhance both humoral and cell-mediated immune responses

An example approach would be to combine regulated ssaK expression with the enhanced T3SS delivery system described for other recombinant proteins in Salmonella .

What are common challenges in studying SsaK and how can they be addressed?

Researchers working with SsaK may encounter several technical challenges:

ChallengePotential Solutions
Low expression levels- Optimize codon usage for expression host
- Test different promoters and expression systems
- Consider co-expression with chaperones
Protein insolubility- Express as fusion with solubility tags (MBP, SUMO)
- Co-express with binding partners SsaN and SsaQ
- Test various detergents if membrane-associated
Complex dissociation- Use gentle purification methods
- Cross-link complexes before analysis
- Optimize buffer conditions to maintain interactions
Functional assays- Develop in vitro reconstitution of T3SS activity
- Create fluorescent reporters for secretion
- Use complementation assays in ssaK mutants
Structural analysis- Try both X-ray crystallography and cryo-EM
- Focus on stable domains if full-length is challenging
- Consider nanobody-based stabilization

Additionally, ensuring proper T3SS-2 inducing conditions is critical, as the C-ring complex containing SsaK only properly localizes to the membrane under these specific conditions .

How can researchers verify the functional integrity of recombinant SsaK?

Verifying that recombinantly produced SsaK retains its native functionality is crucial for meaningful studies. Recommended validation approaches include:

  • Complex formation assay: Demonstrate that recombinant SsaK can form the C-ring complex with SsaN and SsaQ as observed in native systems . This can be assessed by:

    • Analytical size exclusion chromatography

    • Native PAGE analysis

    • Co-immunoprecipitation with recombinant partners

  • Complementation studies: Introduce recombinant SsaK into ssaK-deficient Salmonella and verify:

    • Restoration of T3SS-2 function

    • Recovery of effector secretion

    • Rescue of virulence phenotypes in cellular or animal models

  • Membrane localization: Confirm that recombinant SsaK properly localizes to the membrane fraction under T3SS-2 inducing conditions .

  • Structural integrity assessment:

    • Circular dichroism to verify secondary structure content

    • Limited proteolysis to confirm proper folding

    • Thermal shift assays to assess stability

  • Protein-protein interaction verification:

    • SPR or ITC to quantify binding to known partners

    • Pull-down assays to confirm expected interactions

How should researchers analyze protein-protein interaction data involving SsaK?

When analyzing protein-protein interaction data for SsaK, researchers should follow these methodological steps:

  • Establish appropriate controls:

    • Positive controls: Known interactions (e.g., SsaK with SsaN and SsaQ)

    • Negative controls: Proteins not expected to interact with SsaK

    • Technical controls: Tag-only or denatured protein controls

  • Quantitative analysis approaches:

    • For SPR or ITC data: Calculate KD, kon, and koff values

    • For co-IP experiments: Normalize pull-down efficiency across samples

    • For two-hybrid assays: Compare signal strength to establish relative interaction strengths

  • Validation across multiple methods:

    • Confirm key interactions using at least two independent techniques

    • Address any discrepancies between different methodological approaches

    • Consider how experimental conditions might affect interaction detection

  • Bioinformatic integration:

    • Map interaction sites to predicted protein domains

    • Compare with homologous systems from other species

    • Build interaction network models incorporating all known T3SS components

  • Functional correlation:

    • Connect interaction data with functional outcomes in secretion assays

    • Assess how mutations affecting interactions impact T3SS-2 function

    • Determine the biological significance of each interaction

What statistical approaches are appropriate for analyzing SsaK mutant phenotypes?

When evaluating phenotypes of ssaK mutants or variants, appropriate statistical approaches include:

  • For virulence studies:

    • Survival analysis (Kaplan-Meier curves) for infection outcomes

    • Log-rank test to compare survival curves between groups

    • Multiple comparison corrections (Bonferroni, Benjamini-Hochberg) when testing several mutants

  • For bacterial replication assays:

    • ANOVA followed by post-hoc tests for comparing multiple strains

    • Linear mixed models when working with repeated measures or nested data

    • Power analysis to determine appropriate sample sizes

  • For protein secretion quantification:

    • Paired t-tests for comparing wild-type vs. mutant secretion levels

    • Regression analysis for dose-response relationships

    • Non-parametric tests (Mann-Whitney U) when normality cannot be assumed

  • For structural impact assessment:

    • Cluster analysis to group similar structural perturbations

    • Principal component analysis to identify major modes of structural variation

    • Correlation analysis between structural parameters and functional outcomes

  • For high-throughput datasets:

    • False discovery rate control for multiple hypothesis testing

    • Enrichment analysis for identifying affected pathways

    • Machine learning approaches for identifying patterns in complex datasets

What emerging technologies could advance our understanding of SsaK function?

Several cutting-edge technologies hold promise for deepening our understanding of SsaK:

  • Cryo-electron tomography: Could reveal the native structure of the SsaK-containing C-ring complex within intact bacterial cells, providing insights into how it connects to other T3SS components.

  • AlphaFold and structure prediction: AI-based structure prediction could generate models of SsaK and its complexes to guide experimental approaches.

  • Single-molecule techniques: Including single-molecule FRET to study conformational changes in SsaK during T3SS activation and protein translocation.

  • Proximity labeling approaches: BioID or APEX2 fusions to SsaK could identify transient or weak interacting partners in living bacteria under physiological conditions.

  • CRISPR interference: CRISPRi approaches could allow tunable repression of ssaK expression to study dose-dependent effects on T3SS assembly and function.

  • Microfluidics combined with live imaging: To observe T3SS dynamics in real-time during host cell infection, potentially capturing SsaK's role in the secretion process.

  • Mass spectrometry-based structural techniques: Such as hydrogen-deuterium exchange mass spectrometry (HDX-MS) to map interaction surfaces and conformational changes of SsaK.

How might SsaK be engineered to create novel protein delivery systems?

The involvement of SsaK in the T3SS-2 protein delivery machinery suggests several promising engineering possibilities:

  • Targeted protein delivery platforms: Engineering the SsaK-containing complex to recognize specific cell types could enable:

    • Delivery of therapeutic proteins to specific tissues

    • Reduced off-target effects compared to current delivery methods

    • Applications in both research and clinical settings

  • Enhanced vaccine development: As demonstrated in research with Salmonella-based platforms , modified T3SS systems could:

    • Deliver multiple classes of recombinant proteins into eukaryotic cells

    • Target antigens directly to the cytosol of antigen-presenting cells

    • Potentially enhance both humoral and cell-mediated immunity

  • Biosensor applications: Creating fusion constructs that combine:

    • SsaK's role in the delivery apparatus

    • Reporter proteins or detection molecules

    • Conditional activation elements

  • Synthetic biology tools: Engineering orthogonal protein secretion systems based on modified SsaK that could:

    • Function as modular parts in synthetic biology circuits

    • Allow controlled delivery of proteins between cells

    • Create new cell-cell communication systems

The successful enhancement of T3SS to deliver multiple classes of recombinant proteins into eukaryotic cells demonstrates the feasibility of such engineering approaches.

What potential exists for targeting SsaK in antimicrobial development?

SsaK's essential role in T3SS-2 function and Salmonella virulence makes it a promising target for novel antimicrobial strategies:

  • Small molecule inhibitors: Could be developed to:

    • Disrupt SsaK interactions with SsaN or SsaQ

    • Prevent proper C-ring complex formation

    • Block membrane localization of the complex

  • Peptide-based approaches: Designed peptides could:

    • Mimic interaction interfaces between SsaK and its partners

    • Competitively inhibit complex formation

    • Be delivered via cell-penetrating peptide sequences

  • Anti-virulence strategy advantages:

    • Targeting virulence rather than bacterial survival may reduce selection pressure for resistance

    • Preserving commensal bacteria while inhibiting pathogenic behavior

    • Potentially combining with conventional antibiotics for synergistic effects

  • High-throughput screening opportunities:

    • Developing assays based on SsaK-SsaN-SsaQ complex formation

    • Screening chemical libraries for compounds that disrupt these interactions

    • Using structure-based virtual screening if structural data becomes available

The specificity of SsaK to the virulence machinery rather than to essential cellular processes makes it an attractive target for developing new classes of anti-infective agents with potentially lower resistance development.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.